Concerted action of cellular JNK and Pin1 restricts HIV-1 genome integration to activated CD4+ T lymphocytes

Nature Medicine

Volumn 16, Issue 3, 2010, Pages 329-333

  Manganaro, Lara ^a   Lusic, Marina ^a   Gutierrez, Maria Ines ^a   Cereseto, Anna ^b   Del Sal, Giannino ^c,d   Giacca, Mauro ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^b SCUOLA NORMALE SUPERIORE   (Italy)

^c Laboratorio Nazionale Consorzio Interuniversitario Biotecnologie   (Italy)

^d UNIVERSITY OF TRIESTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; INTEGRASE; PEPTIDYLPROLYL ISOMERASE PIN1; PROTEIN P73; SERINE; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR RELA;

ARTICLE; CD4+ T LYMPHOCYTE; CONFORMATIONAL TRANSITION; ENZYME PHOSPHORYLATION; ENZYME STABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN PROCESSING; VIRUS GENOME;

BLOTTING, WESTERN; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DNA, VIRAL; HIV INFECTIONS; HIV INTEGRASE; HIV-1; HUMANS; LYMPHOCYTE ACTIVATION; MAP KINASE KINASE 4; PEPTIDYLPROLYL ISOMERASE; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; VIRUS INTEGRATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 77949264933     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.2102     Document Type: Article

References (39)

1. + T cells. J. Virol. 79, 2199-2210 (2005)
2. + T cells. Nature 435, 108-114 (2005)
3. Zack, J.A. et al. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61, 213-222 (1990)
4. Stevenson, M., Stanwick, T.L., Dempsey, M.P. & Lamonica, C.A. HIV-1 replication is controlled at the level of T cell activation and proviral integration. EMBO J. 9, 1551-1560 (1990)
5. Weiss, A. & Littman, D.R. Signal transduction by lymphocyte antigen receptors. Cell 76, 263-274 (1994)
6. Rincón, M., Flavell, R.A. & Davis, R.J. Signal transduction by MAP kinases in T lymphocytes. Oncogene 20, 2490-2497 (2001)
7. 2-terminal kinase (Jnk) gene expression during T cell activation. J. Exp. Med. 191, 139-146 (2000)
8. Cereseto, A. et al. Acetylation of HIV-1 integrase by p300 regulates viral integration. EMBO J. 24, 3070-3081 (2005)
9. Pierson, T.C. et al. Molecular characterization of preintegration latency in human immunodefciency virus type 1 infection. J. Virol. 76, 8518-8531 (2002)
10. Suzuki, Y. & Craigie, R. The road to chromatin-nuclear entry of retroviruses. Nat. Rev. Microbiol. 5, 187-196 (2007)
11. Wiskerchen, M. & Muesing, M.A. Human immunodefciency virus type 1 integrase: effects of mutations on viral ability to integrate, direct viral gene expression from unintegrated viral DNA templates and sustain viral propagation in primary cells. J. Virol. 69, 376-386 (1995)
12. Engelman, A., Englund, G., Orenstein, J.M., Martin, M.A. & Craigie, R. Multiple effects of mutations in human immunodefciency virus type 1 integrase on viral replication. J. Virol. 69, 2729-2736 (1995)
13. Whitehurst, C.E., Boulton, T.G., Cobb, M.H. & Geppert, T.D. Extracellular signal-regulated kinases in T cells. Anti-CD3 and 4 β-phorbol 12-myristate 13-acetate-induced phosphorylation and activation. J. Immunol. 148, 3230-3237 (1992)
14. Paolinelli, R., Mendoza-Maldonado, R., Cereseto, A. & Giacca, M. Acetylation by GCN5 regulates CDC6 phosphorylation in the S phase of the cell cycle. Nat. Struct. Mol. Biol. 16, 412-420 (2009)
15. Lu, K.P. & Zhou, X.Z. The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease. Nat. Rev. Mol. Cell Biol. 8, 904-916 (2007)
16. Zhou, X.Z. et al. Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins. Mol. Cell 6, 873-883 (2000)
17. Stukenberg, P.T. & Kirschner, M.W. Pin1 acts catalytically to promote a conformational change in Cdc25. Mol. Cell 7, 1071-1083 (2001)
18. Mantovani, F. et al. Pin1 links the activities of c-Abl and p300 in regulating p73 function. Mol. Cell 14, 625-636 (2004)
19. Zacchi, P. et al. The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults. Nature 419, 853-857 (2002)
20. Ryo, A. et al. Regulation of NF-κB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. Mol. Cell 12, 1413-1426 (2003)
21. Ryo, A., Nakamura, M., Wulf, G., Liou, Y.C. & Lu, K.P. Pin1 regulates turnover and subcellular localization of β-catenin by inhibiting its interaction with APC. Nat. Cell Biol. 3, 793-801 (2001)
22. Uchida, T. et al. Pin1 and Par14 peptidyl prolyl isomerase inhibitors block cell proliferation. Chem. Biol. 10, 15-24 (2003)
23. Llano, M., Delgado, S., Vanegas, M. & Poeschla, E.M. Lens epithelium-derived growth factor/p75 prevents proteasomal degradation of HIV-1 integrase. J. Biol. Chem. 279, 55570-55577 (2004)
24. Mousnier, A. et al. von Hippel Lindau binding protein 1-mediated degradation of integrase affects HIV-1 gene expression at a postintegration step. Proc. Natl. Acad. Sci. USA 104, 13615-13620 (2007)
25. Bukrinsky, M.I., Stanwick, T.L., Dempsey, M.P. & Stevenson, M. Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. Science 254, 423-427 (1991)
26. Chun, T.W. et al. Quantifcation of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 387, 183-188 (1997)
27. + T cells residing within human lymphoid tissues. Immunity 15, 671-682 (2001)
28. + T cells. Science 286, 1353-1357 (1999)
29. Kreisberg, J.F., Yonemoto, W. & Greene, W.C. Endogenous factors enhance HIV infection of tissue naive CD4 T cells by stimulating high molecular mass APOBEC3G complex formation. J. Exp. Med. 203, 865-870 (2006)
30. Yamashita, M. & Emerman, M. Retroviral infection of non-dividing cells: old and new perspectives. Virology 344, 88-93 (2006)
31. Zhang, J., Scadden, D.T. & Crumpacker, C.S. Primitive hematopoietic cells resist HIV-1 infection via p21. J. Clin. Invest. 117, 473-481 (2007)
32. Asada, M. et al. Apoptosis inhibitory activity of cytoplasmic p21(Cip1/WAF1) in monocytic differentiation. EMBO J. 18, 1223-1234 (1999)
33. Schwartz, O., Marechal, V., Friguet, B., Arenzana-Seisdedos, F. & Heard, J.M. Antiviral activity of the proteasome on incoming human immunodefciency virus type 1. J. Virol. 72, 3845-3850 (1998)
34. Santoni de Sio, F.R., Cascio, P., Zingale, A., Gasparini, M. & Naldini, L. Proteasome activity restricts lentiviral gene transfer into hematopoietic stem cells and is down-regulated by cytokines that enhance transduction. Blood 107, 4257-4265 (2006)
35. Repnik, U., Knezevic, M. & Jeras, M. Simple and cost-effective isolation of monocytes from buffy coats. J. Immunol. Methods 278, 283-292 (2003)
36. Tan, W., Zhu, K., Segal, D.J., Barbas, C.F. III & Chow, S.A. Fusion proteins consisting of human immunodefciency virus type 1 integrase and the designed polydactyl zinc fnger protein E2C direct integration of viral DNA into specifc sites. J. Virol. 78, 1301-1313 (2004)
37. Butler, S.L., Hansen, M.S. & Bushman, F.D. A quantitative assay for HIV DNA integration in vivo. Nat. Med. 7, 631-634 (2001)
38. Todorovic, V. et al. Human origins of DNA replication selected from a library of nascent DNA. Mol. Cell 19, 567-575 (2005)
39. Marzio, G., Tyagi, M., Gutierrez, M.I. & Giacca, M. HIV-1 Tat transactivator recruits p300 and CREB-binding protein histone acetyltransferases to the viral promoter. Proc. Natl. Acad. Sci. USA 95, 13519-13524 (1998)